Campylobacter infection and related illness is associated with a substantial economic burden in Germany, according to a study.
Researchers analyzed the use of health care and direct and indirect costs of Campylobacter and care-intensive long-lasting health issues of patients from health insurance data with 26 million members in Germany.
Claims data of insurants with at least one Campylobacter diagnosis in 2017 were provided, of which 9,945 were included in the analysis published in the journal Plos One.
This showed a lower rate of Campylobacter diagnoses than German surveillance data for 2017 but with similar age, gender, and regional distribution. According to both the surveillance and claims data, rates were lowest in the 5 to 14 age group and highest for females aged 20 to 24.
Some people developed post-infectious reactive arthritis, Guillain-Barré syndrome (GBS), inflammatory bowel disease (IBD), and/or irritable bowel syndrome (IBS).
FoodWorld 